← All trials
NCT00386958
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2002
- Primary completion
- Jan 1, 2006
- Completion date
- Jan 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 172
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Los Angeles Biomedical Research InstituteLead sponsor
- Thrasher Research FundCollaborator
- Kolokotrones Family FoundationCollaborator
- Joseph Eye HospitalCollaborator
- University of California, Los AngelesOverall official - principal investigator
- University of California, Los AngelesCollaborator
- University of the PhilippinesCollaborator
- L. V. Prasad Eye InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.